141 related articles for article (PubMed ID: 6164090)
1. Which will be the most useful interferon?
Bocci V
Ric Clin Lab; 1981; 11(1):27-32. PubMed ID: 6164090
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of interferons. A reappraisal.
Bocci V
Tex Rep Biol Med; 1981-1982; 41():336-43. PubMed ID: 6184823
[No Abstract] [Full Text] [Related]
3. Metabolism of interferon (facts and fancy).
Bocci V; Pacini A; Pessina GP; Bargigli V
Ric Clin Lab; 1978; 8(1-2):17-25. PubMed ID: 705176
[TBL] [Abstract][Full Text] [Related]
4. Interferon: pharmacokinetics and toxicity.
Scott GM
Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
[TBL] [Abstract][Full Text] [Related]
5. The role of interferon in cancer therapy: a current perspective.
Goldstein D; Laszlo J
CA Cancer J Clin; 1988; 38(5):258-77. PubMed ID: 2458171
[TBL] [Abstract][Full Text] [Related]
6. Interferons: mechanisms of action and clinical applications.
Parmar S; Platanias LC
Curr Opin Oncol; 2003 Nov; 15(6):431-9. PubMed ID: 14624225
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacokinetics of interferons].
Ogarkov VI; Lapina GF
Antibiot Med Biotekhnol; 1986 Sep; 31(9):712-5. PubMed ID: 2430520
[No Abstract] [Full Text] [Related]
8. [The interferon system. A review of biological principles and clinical uses].
Schneider FJ
Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387
[TBL] [Abstract][Full Text] [Related]
9. [Medical and commercial aspects of human interferon].
von Eichborn JF
Arzneimittelforschung; 1986 Feb; 36(2):279-82. PubMed ID: 2421742
[TBL] [Abstract][Full Text] [Related]
10. Considerations in our search for interferons for clinical use.
Lockart RZ; Knight E
Adv Exp Med Biol; 1978; 110():213-6. PubMed ID: 727042
[TBL] [Abstract][Full Text] [Related]
11. [Perspectives on interferon research and on its therapeutic use].
Montagnier L
Arch Inst Pasteur Tunis; 1981; 58(3):297-312. PubMed ID: 6172080
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic studies of interferons.
Bocci V
Pharmacol Ther; 1981; 13(3):421-40. PubMed ID: 6169099
[No Abstract] [Full Text] [Related]
13. Interferon: status in treatment of skin disease.
Yancey KB; Smith JG
J Am Acad Dermatol; 1980 Dec; 3(6):585-95. PubMed ID: 6162867
[TBL] [Abstract][Full Text] [Related]
14. Mild hyperthermia modulates biological activities of interferons.
Payne J; Nair MP; Ambrus JL; Chadha KC
Int J Hyperthermia; 2000; 16(6):492-507. PubMed ID: 11129261
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin plus interferon versus interferon for chronic hepatitis C.
Brok J; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2005 Jul; (3):CD005445. PubMed ID: 16034976
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology and toxicology of the interferons: an overview.
Mannering GJ; Deloria LB
Annu Rev Pharmacol Toxicol; 1986; 26():455-515. PubMed ID: 2424363
[TBL] [Abstract][Full Text] [Related]
17. Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active.
Schultz U; Rinderle C; Sekellick MJ; Marcus PI; Staeheli P
Eur J Biochem; 1995 Apr; 229(1):73-6. PubMed ID: 7538075
[TBL] [Abstract][Full Text] [Related]
18. Interferon therapy: pharmacokinetic and pharmacological aspects.
Billiau A
Arch Virol; 1981; 67(2):121-33. PubMed ID: 6163417
[No Abstract] [Full Text] [Related]
19. Future developments in interferon therapy.
Boiron M
Int J Cancer Suppl; 1987; 1():41-4. PubMed ID: 2442113
[TBL] [Abstract][Full Text] [Related]
20. Potentials of interferon therapy in the treatment of pancreatic cancer.
Booy S; Hofland L; van Eijck C
J Interferon Cytokine Res; 2015 May; 35(5):327-39. PubMed ID: 25551196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
